Shao-Lee Lin, EVP, Head of R&D and CSO at Horizon Therapeutics, holds 109.67K shares in Horizon Therapeutics (Ticker: HZNP), holds ― shares in Principia Biopharma (Ticker: PRNB), holds ― shares in Surrozen (Ticker: SRZN).
What is the percentage of profitable transactions made by Shao-Lee Lin?
The percentage of profitable transactions made by Shao-Lee Lin is 100%.
What is the average return per transaction made by Shao-Lee Lin?
The average return per transaction made by Shao-Lee Lin is 20.20%.
What stocks does Shao-Lee Lin hold?
Shao-Lee Lin holds: HZNP, PRNB, SRZN, THRD, SLRN stocks.
What was Shao-Lee Lin’s latest transaction?
Shao-Lee Lin latest transaction was an Uninformative Buy of ―.
What was Shao-Lee Lin's most profitable transaction?
Shao-Lee Lin’s most profitable transaction was an Informative Sell of SLRN stock on February 22, 2024. The return on the trade was 25.20%.
What is Shao-Lee Lin's role in Horizon Therapeutics?
Shao-Lee Lin's role in Horizon Therapeutics is EVP, Head of R&D and CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.